Digital tools are used to increase patient access and efficiency in genetic services. We reviewed outcomes of patient-facing digital tools used across the genetic testing journey. Our review found that digital tools can improve patient outcomes and system efficiencies. However, most existing tools are developed for the pre-test phase and cancer setting, limiting our understanding of the utility of digital tools in the post-test phase and other clinical contexts. We also found a misalignment between the purposes of the tools and measured outcomes, making it difficult to properly assess their effectiveness. There is a need for development and robust evaluation of digital tools that can support the entire genetic testing trajectory. (By Stephanie Luca, HBSc, MA, PMP, https://jmg.bmj.com/content/early/2022/09/22/jmg-2022-108653)